|Articles|October 14, 2020
- Pharmaceutical Executive-10-01-2020
- Volume 40
- Issue 10
Pharmaceutical Executive, October 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
The SPAC Makes a Comeback!over 5 years ago
Leadership and Industry Imageover 5 years ago
The Interplay Between COVID-19 Pandemic and NCD Epidemicover 5 years ago
FDA Struggles to Retain Credibilityover 5 years ago
Critical Connection: Patient Services and Product Launchover 5 years ago
Mastering the Transition From Academia to Industryover 5 years ago
Smoothing Access Pathover 5 years ago
The COVID Boost to AI in Global Healthover 5 years ago
Speed and SensitivityNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Eli Lilly’s Continuing GLP-1 Success
2
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
3
JP Morgan 2026: AbbVie Advances its Pipeline
4
JP Morgan 2026: Genmab Prioritizing Sustained Growth Over Next Decade
5

